Report #2899653

Received Jun 10, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: CA
Recovered: Unknown
Vaccinated: Jun 2, 2026
Onset: Jun 2, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
FLU3	INFLUENZA (SEASONAL) (FLUARIX)	GLAXOSMITHKLINE BIOLOGICALS	2	—	—

Symptoms (1)

Extra dose administered

Symptom narrative

received a Second Fluarix dosage, yesterday of the 0.5 ml.; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 55-year-old female patient who received Flu Seasonal TIV Dresden (Fluarix 2025-2026 season) suspension for injection in pre-filled syringe for prophylaxis. Previously administered products included Fluarix (received the first dose of Fluarix in OCT-2025). On 02-JUN-2026, the patient received the 2nd dose of Fluarix 2025-2026 season .5 ml. On 02-JUN-2026, an unknown time after receiving Fluarix 2025-2026 season, the patient experienced extra dose administered (Verbatim: received a Second Fluarix dosage, yesterday of the 0.5 ml.). The outcome of the extra dose administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 03-JUN-2026 The batch number was not provided upon follow up with the reporter.